Amedisys Buys Compassionate Care for $340M, Will Become Third-Largest US Hospice Provider

Amedisys Inc. (Nasdaq: AMED) is executing an industry-shaping deal with one of the country’s largest hospice providers, adding further fuel to a white-hot M&A market. Home health, hospice and personal care powerhouse Amedisys announced Wednesday that is has signed a definitive agreement to acquire Parsippany, New Jersey-based Compassionate Care Hospice for a fixed price of […]

M&A and Financing Newsflash: Justice Department Approves CVS-Aetna Merger, Amedisys Subsidiary Closes Personal Care Deal

Justice Department Approves CVS and Aetna Merger CVS Health Corp. (NYSE: CVS) has secured anti-trust approval for its $69 billion acquisition of Aetna (NYSE: AET), the Justice Department announced Wednesday. The deal was approved on the condition that the company divest Aetna’s Medicare Part D prescription drug plan business to WellCare Health Plans, Inc, a […]

Legislation Targeting Home Health Reforms Gaining Ground on Capitol Hill

Industry-backed legislative efforts to take the teeth out of proposed home health payment reform are gaining ground on Capitol Hill. On Thursday, Rep. Ralph Abraham (R-La.) introduced H.R. 6932, a new bill that amends several provisions of the Bipartisan Budget Act of 2018 to thwart widely opposed behavioral adjustment aspects of the Patient-Driven Groupings Model […]

Humana, Amedisys, Homewatch CareGivers Strategize for New Home Health Paradigm

Home health agencies have traditionally staked their claims within the continuum of care as post-acute service providers, serving patients who are discharged from hospitals, often after experiencing traumatic medical events. Advances in predictive modeling, data analytics and overall care delivery — coupled with a chronically ill patient population — are now prompting the home health […]

Home Health, Hospice Experiencing Unprecedented M&A Action

Thanks to heightened interest from private equity buyers and companies’ efforts to diversify business operations, 2018 has seen an acceleration in the number and size of home health, hospice and personal care transactions. The hot market should continue going forward, although the new home health payment model and sky-high valuations raise some questions about what […]

Home Health Investors Undaunted, Stocks Continue Upward March

Not much has shaken home health stocks so far in 2018 — not even the proposed Patient-Driven Groupings Model (PDGM) or the potential introduction of an updated pre-claim review initiative. Home health stocks appear to be continuing their upward march, according to the most recent update to Stoneridge Partners’ Home Health Index (HHI), updated monthly. […]

Amedisys Invests in Predictive Analytics Firm Medalogix to Drive Value-Based Strategy

Amedisys, Inc. (Nasdaq: AMED) has landed a minority stake in predictive analytics firm Medalogix. As one of the largest independent home health, hospice and personal care companies in the country, Amedisys has been actively striving to establish arrangements and partnerships with managed care organizations. Its Medalogix investment, announced on Wednesday, will advance that goal by […]

Amedisys, LHC Group, Addus Shares Rise Despite PDGM Concerns

The Centers for Medicare & Medicaid Services (CMS) last month proposed an overhaul to the current prospective payment system for the home health industry with a sweeping new model that experts say would drastically increase billing efforts and force a move away from therapy services. So far, the potential negatives of the Patient-Driven Groupings Model […]